Loading…
Drugs Made In America Acquisition II Corp. is projected to rise to $12.16 by 2027, a +21% move from its current price of $10.07. DMII is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $10.05 | $10.07 | $10.10 | +0.04% |
| May 30 | $10.04 | $10.08 | $10.11 | +0.08% |
| May 31 | $10.04 | $10.08 | $10.13 | +0.11% |
| Jun 1 | $10.03 | $10.09 | $10.14 | +0.15% |
| Jun 2 | $10.03 | $10.09 | $10.15 | +0.19% |
| Jun 3 | $10.03 | $10.09 | $10.16 | +0.23% |
| Jun 4 | $10.03 | $10.10 | $10.17 | +0.26% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.03 | $10.10 | $10.17 | +0.26% |
| Week 2 | $10.02 | $10.12 | $10.22 | +0.53% |
| Week 3 | $10.03 | $10.15 | $10.27 | +0.79% |
| Week 4 | $10.04 | $10.18 | $10.32 | +1.06% |
| Week 5 | $10.05 | $10.20 | $10.36 | +1.32% |
| Week 6 | $10.06 | $10.23 | $10.40 | +1.59% |
| Week 7 | $10.07 | $10.26 | $10.45 | +1.85% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Drugs Made In America Acquisition II Corp. (DMII) is a financial services company focused on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination. It does not have significant operations because its primary objective is to source and evaluate one or more businesses for a potential business combination.
It intends to source and evaluate companies focused on the pharmaceutical sector.
Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.
DMII is the Drugs Made In America Acquisition II Corp. trading at $10.06 per share with a market capitalization listed at $640.82M, and it is ranked 2852 by market cap.
The current price sits near the 50-day moving average, and the 30-day range is narrow, indicating a defined near-term trading band. The forecast indicates a neutral stance for 2026, with a path toward bullish growth in subsequent years. Long-range projections show higher average prices and sizable upside, culminating in a 2050 average of $76.03 and a max price of $142.53.
A major floor 1.3% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.7% away) — a key level to hold.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 0.5% above — clearing it would confirm fresh momentum.
Key DMII support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DMII market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.06 | Buy | $10.06 | Buy |
| MA 10 | $10.05 | Buy | $10.05 | Buy |
| MA 20 | $10.03 | Buy | $10.04 | Buy |
| MA 50 | $10.01 | Buy | $10.01 | Buy |
| MA 100 | $9.99 | Buy | $9.99 | Buy |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 82.26 | Sell |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 169.98 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 0.60 | Buy |
| Bollinger %B (20,2) | 1.01 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.02 | Buy |
| Awesome (5,34) | 0.04 | Buy |
| Ultimate (7,14,28) | 95.24 | Sell |
| Momentum (10) | 0.04 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 10.07 | Sell |
| ADX (14) | 35.29 | Buy |
| ATR (14) | 0.00 | Info |
Technical sentiment is BULLISH with an RSI14 of 80 indicating strong momentum and potential overbought conditions.
The 50-day simple moving average is $10.00, with a current price of $10.06. The price faces resistance at $10.06 and has support at $10.00. The 30-day price range is $10.02 to $10.10, and annualized volatility is 1%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $9.88 | $10.07 | $14.21 | 0% | Neutral | |
| $9.61 | $12.16 | $16.31 | +21% | Bullish | |
| $10.41 | $13.55 | $18.87 | +35% | Bullish | |
| $10.49 | $13.97 | $20.03 | +39% | Bullish | |
| $11.80 | $16.06 | $23.58 | +59% | Bullish | |
| $13.75 | $19.07 | $28.62 | +89% | Bullish | |
| $14.84 | $20.96 | $32.07 | +108% | Bullish | |
| $17.03 | $24.46 | $38.09 | +143% | Bullish | |
| $17.97 | $26.23 | $41.50 | +160% | Bullish | |
| $17.56 | $26.02 | $41.80 | +158% | Bullish | |
| $26.43 | $42.01 | $71.85 | +317% | Bullish | |
| $42.42 | $76.09 | $142.63 | +656% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $9.88 | $10.07 | $11.82 | +0.00% |
| June 2026 | $8.71 | $10.24 | $12.32 | +1.66% |
| July 2026 | $8.79 | $10.42 | $12.72 | +1.79% |
| August 2026 | $8.67 | $10.34 | $12.76 | -0.73% |
| September 2026 | $8.75 | $10.50 | $13.07 | +1.51% |
| October 2026 | $9.10 | $10.98 | $13.77 | +4.55% |
| November 2026 | $9.23 | $11.18 | $14.13 | +1.87% |
| December 2026 | $9.18 | $11.18 | $14.21 | -0.04% |
Click any year to see its month-by-month DMII forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect DMII to range from $9.88 to $14.21 through 2026. The $10.07 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The DMII price prediction for 2027 points to an average of $12.16 (low $9.61, high $16.31) — a potential gain of +21% on today's $10.07. Buyers look set to stay in control over this stretch.
In 2028, DMII is projected to trade between $10.41 and $18.87, averaging $13.55 — a potential gain of +35% from today's $10.07. That is up +11% on the projected 2027 average. Momentum favours further upside here.
Drugs Made In America Acquisition II Corp.'s 2029 outlook centres on $13.97, within a $10.49 to $20.03 range. That is up +3% on the projected 2028 average. That marks a +39% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, DMII could reach as high as $23.58, with a base case around $16.06 and support toward $11.80 — roughly +59% from $10.07. Momentum favours further upside here.
Expect DMII to range from $13.75 to $28.62 through 2031. The $19.07 average target implies a +89% move from current prices. That is up +19% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The DMII price prediction for 2032 points to an average of $20.96 (low $14.84, high $32.07) — a potential gain of +108% on today's $10.07. Momentum favours further upside here.
In 2033, DMII is projected to trade between $17.03 and $38.09, averaging $24.46 — a potential gain of +143% from today's $10.07. That is up +17% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Drugs Made In America Acquisition II Corp.'s 2034 outlook centres on $26.23, within a $17.97 to $41.50 range. That is up +7% on the projected 2033 average. That marks a +160% change versus current levels. Momentum favours further upside here.
By 2035, DMII could reach as high as $41.80, with a base case around $26.02 and support toward $17.56 — roughly +158% from $10.07. Buyers look set to stay in control over this stretch.
Expect DMII to range from $26.43 to $71.85 through 2040. The $42.01 average target implies a +317% move from current prices. That is up +61% on the projected 2035 average. Momentum favours further upside here.
The DMII price prediction for 2050 points to an average of $76.09 (low $42.42, high $142.63) — a potential gain of +656% on today's $10.07. Buyers look set to stay in control over this stretch.
Investing $1,000 in DMII today (≈ 99.304866 DMII) could be worth
$7,556.38
+$6,556.38 (+656%) by 2050 · US Dollar
Based on the average projected DMII price of $76.09 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DMIIwould be worth at today's price.
$1,000 invested in DMII on Dec 3, 2025 (≈ 101.214574 DMII) would be worth
$1,019.23
+$19.23 (+1.9%) today · 1.02× · US Dollar
Based on a DMII entry price of $9.88 vs. today's $10.07.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.05 | $1,001.99 | +0.2% |
| 1 month ago | $10.01 | $1,006.5 | +0.6% |
| 3 months ago | $9.98 | $1,009.02 | +0.9% |
| All time ago | $9.88 | $1,019.23 | +1.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DMII forecast.
Our base-case forecast reaches $20.00 around 2032.
Implied market cap at $20.00: $1.27B
The multi-year forecast shows a bullish trajectory, with the 2026 average at $10.06 and a max of $14.24 (neutral sentiment).
From 2027 onward, the forecast projects higher averages and bullish sentiment, with the 2027 average at $12.18 and 2027 max at $16.35. The 2030 average is $16.10, the 2040 average is $41.79, and the 2050 average reaches $76.03, with corresponding max values up to $23.66 in 2030 and $142.53 in 2050. ROI figures rise from 0 in 2026 to 21 in 2027, 34.2 in 2028, 39.1 in 2029, 60 in 2030, 88.9 in 2031, 108.3 in 2032, 143.8 in 2033, 159.7 in 2034, 157.6 in 2035, 315.4 by 2040, and 655.8 by 2050.
The sentiment remains BULLISH across the extended horizon, reflecting a strong upside scenario with acknowledged uncertainty.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $16.10 with a min of $11.83 and a max of $23.66, and an ROI of 60. The sentiment is BULLISH.
Forecasts indicate a bullish trajectory from 2027 onward with rising averages and a positive ROI path (e.g., 2027 avg $12.18; 2030 avg $16.10; 2040 avg $41.79; 2050 avg $76.03; ROI grows to 60 by 2030 and 655.8 by 2050). These are estimates and not guarantees.
Yes. The 2050 max forecast is $142.53, which implies the potential to exceed $100 by 2050. The 2040 max is $71.48, showing the pace of upside accelerates into the later horizon.
The current price is $10.06 and the market capitalization is $640.82M.
DMII is categorized under Financial Services and intends to source and evaluate pharmaceutical-sector companies for a potential business combination.
Drugs Made In America Acquisition II Corp. Community Discussion
0Share your Drugs Made In America Acquisition II Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.